Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 99-3963516 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Working with our partners worldwide , Rare Bird aims to create the first-ever globally approved drug to tackle the transcription factor Myocyte Enhancer Factor 2C MEF2C deficiency within five years.
Total Revenue
$202K
FY2024
Total Expenses
$3K
FY2024
Net Assets
$199K
Program Ratio
—
expenses on programs
Employees
0
Volunteers
1
Board Members
5
Voting
5
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.